Back to results
US 2025/0152534 A1Published application
Method of treatment of parkinson’s disease
AssigneeNeuroDerm, Ltd.
InventorsTal Birnberg, Liat Adar, Itay Perlstein
Life of this patent
Estimating the term…
Abstract
Disclosed is a method for the treatment of a neurological or movement disorder, e.g., Parkinson's disease, in an individual in need thereof, by parenteral administration of levodopa and a dopa decarboxylase inhibitor (DDCI), such as carbidopa, benserazide or any combination thereof, concomitantly with oral administration of levodopa, a DDCI, such as carbidopa, benserazide, or any combination thereof.
Claims21
-55. (canceled)
A method for treatment of a neurological or movement disorder in a patient in need thereof, said method comprising:
- parenterally administering to the patient a first pharmaceutical composition comprising:
- a) levodopa, a levodopa salt, a levodopa prodrug, or any combination thereof;
- and
- b) a dopa decarboxylase inhibitor (DDCI), a DDCI salt, a DDCI prodrug, or any combination thereof;
- and, concomitantly,
- orally administering to the patient a second pharmaceutical composition comprising an active agent selected from the group consisting of levodopa, a levodopa salt, a levodopa prodrug, a dopa decarboxylase inhibitor (DDCI), a DDCI salt, a DDCI prodrug, and any combination thereof.
3 more elements
Dependencies are inferred from the claim text.